Stryker traded at $326.10 this Monday March 30th, decreasing $1.34 or 0.41 percent since the previous trading session. Looking back, over the last four weeks, Stryker lost 15.74 percent. Over the last 12 months, its price fell by 12.40 percent. Looking ahead, we forecast Stryker to be priced at 317.62 by the end of this quarter and at 289.88 in one year, according to Trading Economics global macro models projections and analysts expectations.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. Its segments include Orthopaedics, MedSurg, Neurotechnology and Spine. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The MedSurg segment includes surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment, intensive care disposable products; reprocessed and remanufactured medical devices, and other related products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products. Its products include implants, which are used in joint replacement and trauma surgeries, and other products. It offers musculoskeletal care and sensor technology for total joint replacement.